Violet Guhanshan denies transfer of Nanyue pharmaceutical shares is not yet a transfer condition

NetEase Financial January 19, the night of the ancient Han said the announcement that the company has never been with Hanson investment and China Resources Pharmaceutical group on the transfer of Nanyue pharmaceutical equity issues have been contacts and negotiations.　　Recently, the media published a report entitled "A series of sales of Western medicine assets of the ancient Han ' to seek out the main business" related reports. Violet Guhanshan said that, after verification, the report said the company to Hansen pharmaceutical major shareholder Hanson investment and China Resources Pharmaceutical Group Transfer Nanyue Pharmaceutical equity matters are not true.　　The company has never had contacts and negotiations with Hanson investment and China Resources Pharmaceutical group on the transfer of Nanyue pharmaceutical equity.　　Violet Guhanshan also said that at present, still hold Nanyue pharmaceutical 36% of the equity, because the company and the Nanyue Company's equity issues are disputed, currently does not have the transfer of Nanyue pharmaceutical shares of the conditions, if the two sides dispute resolution, the company has the possibility of transferring Nanyue company shares. Until January 19 Close, purple ancient Han reported 15.20 Yuan, Rose 4.68%.